p21WAF1/cip1 is an important determinant of intestinal cell response to sulindac in vitro and in vivo

Cancer Research

Volumn 61, Issue 16, 2001, Pages 6297-6302

  Yang, WanCai ^a   Velcich, Anna ^a   Mariadason, John ^a   Nicholas, Courtney ^a   Corner, Georgia ^a   Houston, Michele ^a   Augenlicht, Leonard H ^a,b   Edelmann, Winfried ^b   Kucherlapati, Raju ^a   Holt, Peter R ^c  

^a ALBERT EINSTEIN CANCER CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN P21; SULINDAC;

ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CASE REPORT; CELL FUNCTION; CONCENTRATION RESPONSE; DNA MICROARRAY; ENZYME INDUCTION; GENE EXPRESSION; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DUODENUM; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, APC; HUMANS; INTESTINAL MUCOSA; MALE; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECANCEROUS CONDITIONS; RECTUM; SULINDAC;

EID: 0035881323     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Sulindac polyposis of the colon
2. Sulindac causes regression of rectal polyps in familial adenomatous polyposis
3. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
4. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis
5. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis
6. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent
7. Inhibition of cyclooxygenase: A novel approach to cancer prevention
8. Nonsteroidal antiinflammatory drugs and colorectal cancer: Evolving concepts in their chemopreventive actions
9. Self-promotion? Intimate connections between APC and prostaglandin H synthase-2
10. Suppression of intestinal polyposis in Apc716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
11. Anti-inflammatories inhibit cancer growth - But how?
12. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: Comparison with trichostatin A, sulidac, and curcumin and implications for chemoprevention of colon cancer
13. Cluster analysis and display of genome-wide expression patterns
14. Targeted inactivation of the p21 WAF1/cip1 gene enhances Apc-mitiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosa
15. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal minors
16. 1 checkpoint control
17. A mouse model of human familial adenomatous polyposis
18. The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: Alterations in tumor suppressor and cell cycle-regulatory proteins
19. Short-chain fatty acid metabolism, apoptosis and Apc-initiated tumorigenesis in the mouse gastrointestinal mucosa
20. Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines
21. Sodium butyrate induces apoptosis in human colonic minor cell lines in a p53-independent pathway: Implications for the possible role of dietary fibre in the prevention of large-bowel cancer
22. Divergent phenotypic patterns and commitment to apoptosis of Caco-2 cells during spontaneous and butyrate-induced differentiation
23. Down-regulation of B-catenin-TCF signaling is linked to colonic epithelial cell differentiation
24. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate
25. Topological control of p21 waf1/cip1 expression in normal and neoplastic tissues
26. Butyrate induced cell cycle arrest and apoptotic cascade in colonic carcinoma cells: Modulation of the β-catenin-Tcf pathway, and concordance with effects of sulindac and trichostatin, but not curcumin
27. The murine gene p27Kip1 is haplo-insufficient for tumour suppression
28. Retention of wild-type p53 in tumors from p53 heterozygous mice: Reduction of p53 dosage can promote cancer formation
29. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells
30. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma
31. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
32. Loss of B-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene
33. Identification of c-MYC as a target of the APC pathway
34. Identification of CDK4 as a target of c-MYC
35. Mitochondrial regulation of cell death: Mitochondria are essential for procaspase 3-p21 complex formation to resist Fas-mediated cell death
36. 1 cyclin-dependent kinases
37. WAF1, a potential mediator of p53 tumor suppression
38. p21 is a universal inhibitor of cyclin kinases
39. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
40. Expression of cloned sequences in biopsies of human colonic tissue and in colonic carcinoma cells induced to differentiate in vitro
41. Expression of mitochondrial cytochrome c oxidase in human colonic cell differentiation, transformation, and risk for colonic cancer
42. Steady-state levels of mitochondrial messenger RNA species characterize a predominant pathway culminating in apoptosis and shedding of HT29 human colonic carcinoma cells
43. Short chain fatty acid-initiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondrial function
44. Mitochondrial membrane potential in the coordination of p53-independent proliferation and apoptosis pathways in human colonic carcinoma cells
45. Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma
46. De Novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells
47. Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases
48. Transforming growth factor-B and p21: Multiple molecular targets of decorin-mediated suppression of neoplastic growth
49. Cloning and chromosomal mapping of mouse ladinin, a novel basement membrane zone component
50. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis
51. Role of BAX in the apoptotic response to anticancer agents
52. Overexpression of ras in mucus-secreting human colon carcinoma cells of low tumorigenicity